Download the App!
show episodes
 
Artwork

1
Pharma Market Access Insights - from Mtech Access

Mtech Access - Powered by Petauri

Unsubscribe
Unsubscribe
Μηνιαία
 
We explore news and insights from global healthcare markets, advising how pharma and medtech need to respond and adapt their market access strategy in light of the latest insights from our experts. The podcast features insights from our associates across global healthcare, along with thought leadership from the market access and HEOR experts at Mtech Access.
  continue reading
 
Artwork

1
The BAM Effect

Jon Bambalas

Unsubscribe
Unsubscribe
Μηνιαία
 
How does pharma market access fit into HCP engagement strategies? What does it take to improve your field team’s effectiveness and build your brand share? The BAM Effect helps pharma marketers and sales reps stand out and level up their brand’s market access pull-through to drive radical Rx growth. Each week you’ll get an exclusive look at HCP survey data, actionable pharma marketing tips, and real-world examples from pharma sales veterans. We’ll answer your questions, get your team fired up ...
  continue reading
 
Artwork

1
Global Business

China Plus

Unsubscribe
Unsubscribe
Καθημερινά
 
Global Business offers in-depth analysis of the latest economic data, business trends and market moving policies, zooming in on how all this affects ordinary people.
  continue reading
 
Hello Combi-Nation! Our industry fee complicated sometimes. Drugs, devices, clinical trials, submissions, sterilization validation, design control, risk management, market access reimbursement, the list goes on. My name is Subhi Saadeh. I've spent over a decade in medical device, pharma, and combination product development. My goal is mastery, so this podcast is to ask questions I have to people who may have the answers. Whether you're background is Pharma, Device or both, I invite you to li ...
  continue reading
 
Artwork

1
AI For Pharma Growth

Dr. Andree Bates

Unsubscribe
Unsubscribe
Εβδομαδιαία
 
AI For Pharma Growth is the podcast from pioneering Artificial Intelligence entrepreneur Dr. Andree Bates created to help Pharma, Biotech and other Healthcare companies understand how the use of AI-based technologies can easily save them time and grow their brands and company results. This show blends deep experience in the sector with demystifying AI for biopharma execs from biotech start-ups right through to big pharma. In this podcast, Dr Andree will teach you the tried and true secrets t ...
  continue reading
 
Artwork

1
Everybody Hates Pharma

Artem Brytchenko, Stefan Repin, Ahmed Samir Moustafa, Christopher John Bautista,

Unsubscribe
Unsubscribe
Μηνιαία+
 
In the new season join us in this unique journey, where we dive deep into the pharmaceutical industry, sharing not just stories but also the tools and knowledge that power its progress. "Everybody Hates Pharma" – a podcast that seeks to foster transparency and understanding in the world of pharma.
  continue reading
 
Artwork

1
Health Care Rounds

John Marchica

Unsubscribe
Unsubscribe
Μηνιαία
 
Health Care Rounds is a weekly podcast developed for health care leaders who are at the forefront of health care delivery and payment reform. Join Darwin Research Group founder and CEO John Marchica as he discusses the latest advancements in health care business news and policy developments, including interviews with dynamic leaders in health care. John is a veteran health care strategist and is leading ongoing research initiatives on health care delivery systems and value-based care. Tags: ...
  continue reading
 
Artwork
 
The Syneos Health Podcast Series dissects some of the most complex issues biopharma leaders are facing today. Our clinical and commercial experts provide time-tested solutions, as well as perspectives on the news of the day. Hosted by Jeff Stewart, a long-time industry consultant who has advised biopharma leaders on licensing, mergers and acquisitions, pricing and market access, commercialization and go-to-market strategies, each episode explores the challenges and considerations involved wi ...
  continue reading
 
Artwork

1
TKG PACT Executive Briefings - 3-Minute Market Insights

The Kinetix Group, Powered by Petauri

Unsubscribe
Unsubscribe
Μηνιαία
 
Welcome to the TKG PACT Executive Briefing, where in 3-minutes we highlight healthcare’s critical market access issues, policies, challenges, or trends. This resource offers condensed, 3-minute episodes of market insights. Our passion is on achieving the Quintuple Aim of enhancing patient experience, improving population health, reducing costs, improving the work life of health care providers and staff., and enhancing health equity in all aspects of care delivery. I’m Dr. Warren Smedley, tha ...
  continue reading
 
Artwork

1
Reorg Radio

Reorg

Unsubscribe
Unsubscribe
Εβδομαδιαία+
 
Reorg podcasts feature highlights from the previous week, previews of what's to come in the week ahead and deep dives on issues and companies in the distressed and high-yield space. Stay informed on what's discussed on the podcast by requesting trial access to Reorg. We’re looking for feedback to improve the podcast experience! Please share your thoughts by taking the survey:https://www.research.net/r/Reorg_podcast_survey
  continue reading
 
Artwork

1
House Calls

Cain Brothers, a division of KeyBanc Capital Markets

Unsubscribe
Unsubscribe
Μηνιαία
 
Welcome to House Calls, where we talk to investment bankers from Cain Brothers, a division of KeyBank Capital Markets Inc. These bankers are working in some of the most interesting segments of healthcare, with organizations and business models that are helping to change the US healthcare industry. Host David Johnson is a recovering investment banker who discovered he’s actually a journalist and started 4sight Health, a thought leadership and advisory company. Johnson leads the conversation a ...
  continue reading
 
Artwork

1
Healthcare Goes Digital

Impetus Digital

Unsubscribe
Unsubscribe
Μηνιαία
 
We are covering topics on tissue 3D bioprinting, clinical trials in silica, quantum computing in product development, blockchain-powered patient management portals, nanotechnologies, and digital therapeutics. We are also covering topics on leadership in the new pharma paradigm post-COVID-19 and what it will mean to function in the new virtual world we find ourselves in. We will be asking how pharma business models will need to change and what new partnerships will need to develop as a result ...
  continue reading
 
Artwork
 
We believe Mission and Margin is the business of healthcare. Business of Healthcare (BOH) interviews feature innovations sustainably improving healthcare Mission & Margin. Each discussion includes a healthcare executive and innovator concentrating on the same problem. Think “Nightline” or “How I Built This” just for healthcare. Recent guests have included Bernadette Spong, Chief Financial Officer, Orlando Health, Paul Kusserow, President & CEO, Amedisys, Blake Marggraff, Founder & Chief Exec ...
  continue reading
 
Loading …
show series
 
Send us a Text Message. Today’s topic is the The Federal NOPAIN Act. The Federal “Non-Opioids Prevent Addiction In the Nation Act” (or, the “NOPAIN Act”), Senate bill S.586, was signed into law in December 2022. It takes effect this coming January as part of the Centers for Medicare and Medicaid Services 2025 OPPS proposed rule. The NOPAIN Act dire…
  continue reading
 
This week SunPower Corp. is preparing to file chapter 11 to pursue in-court asset sales, Steward Health plans to close two Massachusetts hospitals in the absence of viable bids, MultiPlan is working with Guggenheim Securities to explore balance sheet options because of mounting legal battles, and other interesting developments in the restructuring …
  continue reading
 
--Officials: China will boost its market economy and continue to strengthen its economic growth policies. --Fed hints that rate cuts could start in September. --China issues a five-year action plan for people-centered new urbanization.
  continue reading
 
--Official: Improving the macroeconomic regulation system will be key for the next stage in China. --BoJ lifts interest rates to 0.25% and sets out a tapering plan. --Paris pledges to halve the event's carbon footprint to host the greenest-ever Games.
  continue reading
 
In this episode of AI For Pharma Growth, Dr. Andree Bates is joined by Julien Willard, a Partner and Life Science Lead at IBM. Julien is focused on how AI is being used to tackle global health challenges, particularly in low and middle-income countries (LMICs). Julien & Andree discuss the importance of accounting for local context when implementing…
  continue reading
 
--China sets economic priorities for the second half of the year. --World Gold Council: Total global gold demand rises 4% to 1,258t in Q2. --Inner Mongolia's "solar panel Great Wall" speeds up China's green development.
  continue reading
 
On this episode, I was joined by David Grosse-Wentrup, Research Director for Human Factors at Design Science Group. David walks through: David Grosse-Wentrup PhD is a Research Director at Design Science, a global human factors consultancy focused on advancing healthcare technology through user research and design evaluation. After his studies in bi…
  continue reading
 
This week on The Reorg Primary View, Javier Garibay, a senior associate at Mayer Brown in Mexico City specializing in M&A and restructuring, talks with Reorg's Maria Abreu about the challenges in restructuring Mexican companies that have issued bonds governed by U.S. law and are navigating commercial bankruptcy in Mexico, as well as strategies for …
  continue reading
 
--China and Italy will deepen cooperation in trade, investment, and cultural exchanges. --Regulator: China sees stable growth of patent and trademark applications by foreign entities. --Purchases of gold bars and coins jumped 46% in H1.
  continue reading
 
--China's state asset authorities pledge deeper reforms to boost competitiveness. --Chinese companies take center stage at the Paris Olympics as suppliers of souvenirs and equipment. --G20 Finance Ministers meet in Rio de Janeiro to discuss global 2% income tax on the super-rich.
  continue reading
 
--China's summer grain yield of nearly 150 billion kilograms surpasses all previous years. --Entrepreneurs from Taiwan are establishing various businesses in Wuxi. --Delta Airlines faces investigation by the U.S. Transport Department following a global IT outage lasting four days.
  continue reading
 
On this episode, I was joined by David Simoens, Founder of Life Science Professionals Inc. David walks through the freeze drying(lyo) process, primary drying via sublimation, secondary drying through desorption, and final steps such as backfilling and stoppering. David also explores the different considerations for lyophilization, the impact of var…
  continue reading
 
In this episode of AI For Pharma Growth, Dr. Andree Bates talks to Dr Andrew Rut, CEO of Metadvice, about how AI is at the forefront of improvements to the pharmaceutical industry. Metadvice uses neural networks to enable clinicians to handle patients faster and with greater accuracy. It utilises both synthetic and real data to achieve an incredibl…
  continue reading
 
Send us a Text Message. The High-Value Pharmacy Enterprise Framework. The High-Value Pharmacy Enterprise Framework is a collection of evidence-based and expert recommended best practices designed to enhance health system pharmacy operations by ensuring safe, effective, and patient-centered medication management throughout the health-system pharmacy…
  continue reading
 
This week on The Reorg Primary View, Alex Belgrade, managing partner at Valitana, joins Reorg’s Hugh Minch to discuss how CLO managers and tranche investors have reacted to periods of volatility in the credit markets. Belgrade discusses strategies that involve a combination of information asymmetry and quick reaction time, with particular focus on …
  continue reading
 
--IMF raises China's 2024 economic growth forecast to 5% from April's previous 4.6% outlook. --Local governments in China empower tech commercialization through ownership reform. --Gold price hits an all-time high of over $2,482 per ounce.
  continue reading
 
On this episode, I was joined by Ryan Hoshi, Director of Regulatory Policy and Intelligence at AbbVie. Ryan discusses: 01:18 Understanding Regulatory Policy 03:18 Ryan's Career Journey 05:08 Challenges in Regulatory Harmonization 06:54 Legislative Frameworks and Regulatory Differences Globally 11:10 FDA's Role and Recent Legislation (User Fee reaut…
  continue reading
 
In this episode of AI For Pharma Growth, Dr. Andree Bates explores the pivotal role of AI in boosting team productivity within pharmaceutical companies, alongside Tim Cakir, CEO of TaskDrive. Tim's insights stem from his background as a growth consultant, driving TaskDrive's evolution towards AI-augmented virtual assistants and achieving remarkable…
  continue reading
 
--The output, new orders, and orders-on-hand of China's shipbuilding industry continued to expand in H1. --China’s private enterprises achieve rapid development under deepening reforms. --Chinese immersive theater makes "time travel" possible.
  continue reading
 
Join us for an exclusive interview with Mike Dennis, the co-head of European Credit at Ares, which manages nearly €70 billion in assets. In this episode, Mike shares his insights on the current state of the direct lending market, the impact of syndicated loans, fundraising challenges, and emerging trends in private credit. Listen to gain valuable p…
  continue reading
 
Send us a Text Message. Introduction to Targeted Therapies: Monoclonal Antibodies Targeted Therapy is the foundation of Precision Medicine. Targeted therapy is a type of personalized treatment that targets specific proteins that control how cells grow, divide, and spread. Antibodies are produced naturally by our body and help the immune system reco…
  continue reading
 
This week on The Reorg Primary View, host Katherine Schwartz sits down with Jeremy Burton, a portfolio manager on the leveraged finance team at PineBridge. Together, they delve into the current mood of the high-yield and leveraged loan markets this summer. Key topics include the impact of the upcoming election on new-money issuance, the rise of lia…
  continue reading
 
On this episode, I was joined by David DeSalvo, Vice-President of Combination Product Development at Kindeva Drug Delivery. David and I discuss: 00:00 Introduction and Guest Overview00:04 David DeSalvo's Career Journey02:13 Understanding Injection Systems04:22 Early Career at BD10:51 Transition to SHL17:50 Starting a New Venture24:54 Experience at …
  continue reading
 
--China's consumer prices see positive growth for five consecutive months. --China's promotion of high-level institution-based openness in finance provides new opportunities for the global market. --Fed Chair Jerome Powell signals a rate cut could be near.
  continue reading
 
In this episode, Dr. Andree Bates speaks with Jordan Miller, Founder of Satori, an open-source, decentralised AI prediction network. The project integrates AI and machine learning to enhance predictive capabilities. Jordan has spent the last decade building a worldwide prediction AI network and the past two years bringing it to life. His career as …
  continue reading
 
The World Economic Forum projects that by 2050, climate change could cause 14 million additional deaths and $12 trillion in global healthcare costs. And this will exacerbate global health inequities with our most vulnerable populations, including women, youth, elderly, lower-income groups, and hard-to-reach communities bearing the brunt of this cha…
  continue reading
 
--2024 China Internet Conference opens to promote digital cooperation. --Rural China sees incomes double and a surge in e-commerce amid an infrastructure boom. --French Prime Minister Gabriel Attal will stay on as the political deadlock continues.
  continue reading
 
--China-Tajikistan bilateral trade reaches 3.93 bln USD in 2023, up more than 50% from a year ago. --Global brands extend their reach to central and western China. --China and the U.S. lead global AI innovation as new entrants surge in 2023.
  continue reading
 
On this episode, I was joined by Alan Stevens and Rumi Young who walk through the contents of the FDA Draft Essential Drug Delivery Outputs for Devices Intended toDeliver Drugs and Biological Products Guidance for Industry. Industry Comments are DUE 9/29/2024.Alan Stevens is the Global Head of Complex Devices and Drug Delivery Systems at AbbVie wit…
  continue reading
 
In this episode, Dr. Andree Bates speaks with Professor Shafi Ahmed and discusses how innovation and disruptive thinking can transform healthcare, making it more accessible and affordable for everyone. Professor Shafi Ahmed is a renowned surgeon and co-founder of Medical Realities, a company pioneering the use of virtual and augmented reality in me…
  continue reading
 
This week, Jon F. Weber speaks with Reorg’s Jason Sanjana about how post-reorganization boards of directors differ from boards in other contexts and can be vital to a successful reorganization. Weber helps creditors manage operationally intensive investments and recently published an article on optimizing board searches, which we discuss.And as alw…
  continue reading
 
--Peruvian President Dina Boluarte visits Nanshan Museum and Huawei in Shenzhen. --Energy transition, green finance, and climate leadership are on the top agenda of this year's Summer Davos. --Participants share their views on the 2nd Belt and Road International Skills Competition.
  continue reading
 
On this episode of the podcast, I was joined by Ben Locwin, Executive SME at Black Diamond Networks. Ben and I discuss: 01:53 Material Qualification Discussion Begins02:23 Material Qualification in Drugs vs. Devices04:00 Quality Standards in Different Industries08:54 Quality Tools and Their Applications11:22 Material Qualification and Supplier Mana…
  continue reading
 
Loading …

Οδηγός γρήγορης αναφοράς